Ignite Creation Date:
2024-05-06 @ 9:43 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03051906
Status:
NOT_YET_RECRUITING
Last Update Posted:
2017-11-22
First Post:
2017-02-06
Brief Title:
Durvalumab Cetuximab and Radiotherapy in Head Neck Cancer
Sponsor:
Azienda Ospedaliero-Universitaria Careggi
Organization:
Azienda Ospedaliero-Universitaria Careggi
Organization Data
Organization:
Azienda Ospedaliero-Universitaria Careggi
Class:
OTHER
Study ID:
DUCRO-HN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Azienda Ospedaliero-Universitaria Careggi
Lead Sponsor Class:
OTHER
Responsible Party:
Lorenzo Livi
Responsible Party Title:
Professor Chair of Radiation Oncology Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Azienda Ospedaliero-Universitaria Careggi
Old Name:
None
Old Organization:
None